Literature DB >> 17063272

Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.

Kyndaron S Reinier1, Pamela M Vacek, Berta M Geller.   

Abstract

Risk factors for breast carcinoma in situ and invasive breast cancer were compared using data from 61,844 women (61% post-menopausal) with no prior breast cancer and at least one screening mammogram between April 1, 1996 and June 30, 2001. The women were followed until a subsequent mammogram before July 1, 2001, or a benign biopsy or breast cancer diagnosis before June 30, 2002. A total of 1,191 breast cancers (300 in situ and 891 invasive) were diagnosed during an average follow-up of 3.1 years. Multivariate Cox regression models were used to estimate the relative risks (RR) of in situ and invasive cancer associated with family history of breast cancer, age at first childbirth or nulliparity, post-menopausal hormone use, body mass index (BMI), and mammographic breast density. Separate analyses were done for pre- and post-menopausal women. BMI was unrelated to risk of in situ cancer regardless of menopausal status, but was associated with an increased risk of invasive cancer in post-menopausal women (RR = 1.9 for BMI > or = 30 vs. BMI < 22, 95% confidence interval 1.4-2.5). Later childbearing and nulliparity were more strongly associated with in situ than invasive cancer in pre-menopausal women. Post-menopausal hormone use was more strongly associated with invasive disease. RR associated with family history and breast density were similar for in situ cancer and invasive cancer. Results indicating that BMI is related to post-menopausal invasive cancers but unrelated to in situ cancers are consistent with the hypothesis that concomitants of obesity activate proliferation.

Entities:  

Mesh:

Year:  2006        PMID: 17063272     DOI: 10.1007/s10549-006-9375-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  27 in total

1.  The impact of obesity on follow-up after an abnormal screening mammogram.

Authors:  Ellen A Schur; Joann E Elmore; Tracy Onega; Karen J Wernli; Edward A Sickles; Sebastien Haneuse
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-05       Impact factor: 4.254

2.  Postmenopausal hormone therapy and ductal carcinoma in situ: a population-based case-control study.

Authors:  Lisa Calvocoressi; Meredith H Stowe; Darryl Carter; Elizabeth B Claus
Journal:  Cancer Epidemiol       Date:  2012-02-06       Impact factor: 2.984

3.  Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.

Authors:  Henry M Kuerer; Sara A Lari; Banu K Arun; Chung-Yuan Hu; Abenaa Brewster; Elizabeth A Mittendorf; Constance T Albarracin; Gildy V Babiera; Abigail S Caudle; Jamie L Wagner; Jennifer K Litton; Isabelle Bedrosian; Funda Meric-Bernstam; Anthony Lucci; Kelly K Hunt
Journal:  Breast Cancer Res Treat       Date:  2012-03-04       Impact factor: 4.872

4.  Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.

Authors:  Lusine Yaghjyan; Graham A Colditz; Laura C Collins; Stuart J Schnitt; Bernard Rosner; Celine Vachon; Rulla M Tamimi
Journal:  J Natl Cancer Inst       Date:  2011-07-27       Impact factor: 13.506

Review 5.  Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.

Authors:  Heidi D Nelson; Bernadette Zakher; Amy Cantor; Rongwei Fu; Jessica Griffin; Ellen S O'Meara; Diana S M Buist; Karla Kerlikowske; Nicolien T van Ravesteyn; Amy Trentham-Dietz; Jeanne S Mandelblatt; Diana L Miglioretti
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

6.  Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.

Authors:  Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2010-06-18       Impact factor: 6.466

Review 7.  The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis.

Authors:  Jessica McCready; Lisa M Arendt; Jenny A Rudnick; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2010-06-17       Impact factor: 6.466

Review 8.  Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy.

Authors:  Madhuri Kakarala; Max S Wicha
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

9.  Obesity, mammography use and accuracy, and advanced breast cancer risk.

Authors:  Karla Kerlikowske; Rod Walker; Diana L Miglioretti; Arati Desai; Rachel Ballard-Barbash; Diana S M Buist
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

10.  A novel unidirectional cross-talk from the insulin-like growth factor-I receptor to leptin receptor in human breast cancer cells.

Authors:  Tuba Ozbay; Rita Nahta
Journal:  Mol Cancer Res       Date:  2008-05-30       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.